Is a complete BCBA/AZN research report available?

No complete published report is available for bcba/AZN (BCBA/AZN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/AZN (BCBA/AZN)

Buenos Aires Stock Exchange: BCBA/AZN · ARS

ARS 70,225

-1726.84 (-2.4%)· Recorded snapshot

Market cap	407.1T
Revenue (ttm)	90.9T
Net income (ttm)	15.5T
EPS (ttm)	ARS 2,769
P/E (trailing)	25.4x
P/E (forward)	15.8x
Dividend	ARS 1,041 (1.48%)
Volume	1,295

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 90.9T
Net income (ttm): 15.5T
EPS (ttm): ARS 2,769
P/E (trailing): 25.4x
P/E (forward): 15.8x
Market cap: 407.1T

Metric	Value
Amount currency	ARS
Country	United Kingdom
Country code	AR
Earnings date	2026-10-30
Employees	96,100
Employees change	1,800
Employees growth	1.91%
Enterprise value	ARS 449.4T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1992
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT112489
Last earnings date	2026-07-27
Last refreshed	2026-10-28
Market cap	ARS 407.1T
Next earnings date	2026-10-30
Price	ARS 70,225.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/AZN
Website	https://www.astrazeneca.com

Metric

Value

Amount currency

ARS

Country

United Kingdom

Country code

Earnings date

2026-10-30

Employees

96,100

Employees change

1,800

Employees growth

1.91%

Enterprise value

ARS 449.4T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1992

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT112489

Last earnings date

2026-07-27

Last refreshed

2026-10-28

Market cap

ARS 407.1T

Next earnings date

2026-10-30

Price

ARS 70,225.00

Price currency

ARS

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

bcba/AZN

Website

https://www.astrazeneca.com

Metric	Value
Average P/E ratio (10Y)	84.65x
Average P/E ratio (3Y)	30.99x
Average P/E ratio (5Y)	130.79x
Earnings yield	3.94%
EV/Earnings	29.04x
EV/EBIT	19.46x
EV/EBITDA	14.11x
EV/FCF	28.44x
EV/Sales	4.75x
FCF / EV yield	3.52%
FCF yield	3.88%
Forward P/E	15.78x
Graham number	27808.76091
Graham upside	-60.4%
Lynch fair value	ARS 60,343.77
Lynch upside	-14.07%
P/(FCF - SBC) ratio	26.67x
P/(OCF - SBC) ratio	20.61x
P/B ratio	5.45x
P/E ratio	25.36x
P/FCF ratio	25.76x
P/OCF ratio	20.06x
P/S ratio	4.48x
Price/EBITDA ratio	13.57x

Metric

Value

Average P/E ratio (10Y)

84.65x

Average P/E ratio (3Y)

30.99x

Average P/E ratio (5Y)

130.79x

Earnings yield

3.94%

EV/Earnings

29.04x

EV/EBIT

19.46x

EV/EBITDA

14.11x

EV/FCF

28.44x

EV/Sales

4.75x

FCF / EV yield

3.52%

FCF yield

3.88%

Forward P/E

15.78x

Graham number

27808.76091

Graham upside

-60.4%

Lynch fair value

ARS 60,343.77

Lynch upside

-14.07%

P/(FCF - SBC) ratio

26.67x

P/(OCF - SBC) ratio

20.61x

P/B ratio

5.45x

P/E ratio

25.36x

P/FCF ratio

25.76x

P/OCF ratio

20.06x

P/S ratio

4.48x

Price/EBITDA ratio

13.57x

Metric	Value
EBIT margin	24.42%
EBITDA margin	33%
Effective tax rate	16.95%
FCF margin	16.74%
Gross margin	81.69%
Operating margin	24.42%
Pretax margin	20.51%
Profit margin	17.02%
Profit per employee	ARS 161M
Profitable quarters	18
Profitable years	36
Revenue per employee	ARS 946M
ROA	8.21%
ROA (5Y)	5.95%
ROCE	17.78%
ROE	21.96%
ROE (5Y)	13.03%
ROIC	16.43%
ROIC (5Y)	13.29%
SBC / revenue	0.6%
Tax / revenue	3.48%

Metric

Value

EBIT margin

24.42%

EBITDA margin

33%

Effective tax rate

16.95%

FCF margin

16.74%

Gross margin

81.69%

Operating margin

24.42%

Pretax margin

20.51%

Profit margin

17.02%

Profit per employee

ARS 161M

Profitable quarters

Profitable years

Revenue per employee

ARS 946M

ROA

8.21%

ROA (5Y)

5.95%

ROCE

17.78%

ROE

21.96%

ROE (5Y)

13.03%

ROIC

16.43%

ROIC (5Y)

13.29%

SBC / revenue

0.6%

Tax / revenue

3.48%

Metric	Value
EPS growth	25.84%
EPS growth (Q)	2.55%
EPS growth (QoQ)	-18.27%
EPS growth 10Y	14.33%
EPS growth 3Y	19.13%
EPS growth 5Y	18.4%
EPS growth years	4
FCF growth	-4.55%
FCF growth (Q)	-22.92%
FCF growth (QoQ)	-25.25%
FCF growth 3Y	5.66%
FCF growth 5Y	14.81%
Gross profit growth	7.69%
Gross profit growth (Q)	7.25%
Gross profit growth 3Y	9.19%
Gross profit growth 5Y	17.24%
Net income growth	25.93%
Net income growth (Q)	2.33%
Net income growth (QoQ)	-18.6%
Net income growth 3Y	19.23%
Net income growth 5Y	22.6%
Net income growth years	4
OCF growth	2.32%
OCF growth (Q)	-15.39%
OCF growth (QoQ)	-14.71%
OCF growth 10Y	14.02%
OCF growth 3Y	10.41%
OCF growth 5Y	16.27%
Operating income growth	5.8%
Operating income growth (Q)	2.88%
Operating income growth 3Y	9.95%
Operating income growth 5Y	31.31%
Revenue growth	8.61%
Revenue growth (Q)	6.41%
Revenue growth (QoQ)	0.63%
Revenue growth 10Y	9.81%
Revenue growth 3Y	11.32%
Revenue growth 5Y	15.75%
Revenue growth quarters	13
Revenue growth years	7

Metric

Value

EPS growth

25.84%

EPS growth (Q)

2.55%

EPS growth (QoQ)

-18.27%

EPS growth 10Y

14.33%

EPS growth 3Y

19.13%

EPS growth 5Y

18.4%

EPS growth years

FCF growth

-4.55%

FCF growth (Q)

-22.92%

FCF growth (QoQ)

-25.25%

FCF growth 3Y

5.66%

FCF growth 5Y

14.81%

Gross profit growth

7.69%

Gross profit growth (Q)

7.25%

Gross profit growth 3Y

9.19%

Gross profit growth 5Y

17.24%

Net income growth

25.93%

Net income growth (Q)

2.33%

Net income growth (QoQ)

-18.6%

Net income growth 3Y

19.23%

Net income growth 5Y

22.6%

Net income growth years

OCF growth

2.32%

OCF growth (Q)

-15.39%

OCF growth (QoQ)

-14.71%

OCF growth 10Y

14.02%

OCF growth 3Y

10.41%

OCF growth 5Y

16.27%

Operating income growth

5.8%

Operating income growth (Q)

2.88%

Operating income growth 3Y

9.95%

Operating income growth 5Y

31.31%

Revenue growth

8.61%

Revenue growth (Q)

6.41%

Revenue growth (QoQ)

0.63%

Revenue growth 10Y

9.81%

Revenue growth 3Y

11.32%

Revenue growth 5Y

15.75%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -4.5T
Depreciation and amortization	ARS 8.1T
EBIT	ARS 22.2T
EBITDA	ARS 30T
EPS	ARS 2,768.69
Financing cash flow	ARS -11.4T
Free cash flow	ARS 15.8T
Free cash flow minus SBC	ARS 15.3T
Gross profit	ARS 74.3T
Income taxes	ARS 3.2T
Investing cash flow	ARS -12.1T
Net borrowing	ARS -2.9T
Net cash flow	ARS -3.2T
Net income	ARS 15.5T
Operating cash flow minus SBC	ARS 19.8T
Operating income	ARS 22.2T
Revenue	ARS 90.9T
Stock-based compensation	ARS 542.2B

Metric

Value

Capital expenditures

ARS -4.5T

Depreciation and amortization

ARS 8.1T

EBIT

ARS 22.2T

EBITDA

ARS 30T

EPS

ARS 2,768.69

Financing cash flow

ARS -11.4T

Free cash flow

ARS 15.8T

Free cash flow minus SBC

ARS 15.3T

Gross profit

ARS 74.3T

Income taxes

ARS 3.2T

Investing cash flow

ARS -12.1T

Net borrowing

ARS -2.9T

Net cash flow

ARS -3.2T

Net income

ARS 15.5T

Operating cash flow minus SBC

ARS 19.8T

Operating income

ARS 22.2T

Revenue

ARS 90.9T

Stock-based compensation

ARS 542.2B

Metric	Value
Altman Z-Score	3.58
Book value per share	ARS 48,041.29
Debt / EBITDA	1.57
Debt / equity	0.64
Debt / FCF	3.03
Goodwill	ARS 32.6T
Interest coverage	10.64
Long-term assets	ARS 128.6T
Long-term liabilities	ARS 48.4T
Net cash (debt)	ARS -40.6T
Net cash / market cap	-9.97%
Net debt / EBITDA	1.35
Net debt / equity	0.54
Net debt / FCF	2.57
Piotroski F-Score	7
Property, plant and equipment	ARS 25.1T
Shareholders' equity	ARS 74.6T
Tangible book value	ARS -12.8T
Tangible book value per share	ARS -8,223.23
Total assets	ARS 171.6T
Total cash	ARS 7.4T
Total debt	ARS 47.9T
Total liabilities	ARS 97T

Metric

Value

Altman Z-Score

3.58

Book value per share

ARS 48,041.29

Debt / EBITDA

1.57

Debt / equity

0.64

Debt / FCF

3.03

Goodwill

ARS 32.6T

Interest coverage

10.64

Long-term assets

ARS 128.6T

Long-term liabilities

ARS 48.4T

Net cash (debt)

ARS -40.6T

Net cash / market cap

-9.97%

Net debt / EBITDA

1.35

Net debt / equity

0.54

Net debt / FCF

2.57

Piotroski F-Score

Property, plant and equipment

ARS 25.1T

Shareholders' equity

ARS 74.6T

Tangible book value

ARS -12.8T

Tangible book value per share

ARS -8,223.23

Total assets

ARS 171.6T

Total cash

ARS 7.4T

Total debt

ARS 47.9T

Total liabilities

ARS 97T

Metric	Value
Asset turnover	0.54
Current assets	ARS 43T
Current liabilities	ARS 48.5T
Current ratio	0.89
Inventory turnover	1.68
Net working capital	ARS -3.3T
Quick ratio	0.66
Working capital	ARS -5.3T
Working capital turnover	-22,214.72

Metric

Value

Asset turnover

0.54

Current assets

ARS 43T

Current liabilities

ARS 48.5T

Current ratio

0.89

Inventory turnover

1.68

Net working capital

ARS -3.3T

Quick ratio

0.66

Working capital

ARS -5.3T

Working capital turnover

-22,214.72

Metric	Value
Buyback yield / dilution	0.03%
Dividend growth	30.81%
Dividend growth (10Y)	44.17%
Dividend growth (3Y)	93.54%
Dividend growth (5Y)	107.84%
Dividend growth years	4
Dividend payment date	2026-09-08
Dividend payment years	5
Dividend payout frequency	Semi-Annual
Dividend per share	ARS 1,040.86
Dividend yield	1.48%
Ex-dividend date	2026-08-07
Last dividend	ARS 358.06
Payout ratio	45.73%
Shareholder yield	1.51%

Metric

Value

Buyback yield / dilution

0.03%

Dividend growth

30.81%

Dividend growth (10Y)

44.17%

Dividend growth (3Y)

93.54%

Dividend growth (5Y)

107.84%

Dividend growth years

Dividend payment date

2026-09-08

Dividend payment years

Dividend payout frequency

Semi-Annual

Dividend per share

ARS 1,040.86

Dividend yield

1.48%

Ex-dividend date

2026-08-07

Last dividend

ARS 358.06

Payout ratio

45.73%

Shareholder yield

1.51%

Metric	Value
150-day SMA	ARS 68,065.17
1D price change	-2.4%
1M price change	4.19%
1M total return	4.19%
1W price change	5.56%
1W total return	5.56%
1Y price change	7.63%
1Y return CAGR	9.31%
1Y total return	9.3%
20-day SMA	ARS 66,522.50
200-day SMA	ARS 69,061.50
3M price change	4%
3M total return	4.65%
3Y price change	152.81%
3Y return CAGR	38.35%
3Y total return	164.86%
50-day SMA	ARS 65,909.50
50-day SMA vs 200-day SMA	50under200
52-week high	ARS 80,275.00
52-week high date	2026-07-03
52-week low	ARS 54,750.00
52-week low date	2025-10-27
5Y price change	1,020.64%
5Y return CAGR	64.07%
5Y total return	1,088.6%
6M price change	-0.92%
6M total return	-0.29%
All-time high	ARS 80,275.00
All-time high date	2026-07-03
All-time low	ARS 3,038.00
All-time low date	2020-09-04
Average true range (ATR)	ARS 1,476.20
Average volume	750.8
Change from 52-week high	-12.52%
Change from 52-week low	28.27%
Change from all-time high	-12.52%
Change from all-time low	2,211.55%
Change from open	-1.4%
Day's gap	-1.01%
Dollar volume	ARS 90.9M
High price	ARS 71,325.00
Low price	ARS 70,100.00
Monthly RSI	62.83
Open price	ARS 71,225.00
Position in 52-week range	10.2%
Previous close	ARS 71,950.00
Price vs 150-day SMA	3.17%
Price vs 20-day SMA	5.57%
Price vs 200-day SMA	1.68%
Price vs 50-day SMA	6.55%
Relative volume	1.72
RSI	61.64
Sharpe ratio	0.29
Sharpe ratio (3Y)	0.99
Sharpe ratio (5Y)	1.45
Sortino ratio	0.56
Sortino ratio (3Y)	1.68
Sortino ratio (5Y)	2.42
Volume	1.3K
Weekly RSI	54.85
YTD price change	-0.46%
YTD total return	1.09%

Metric

Value

150-day SMA

ARS 68,065.17

1D price change

-2.4%

1M price change

4.19%

1M total return

4.19%

1W price change

5.56%

1W total return

5.56%

1Y price change

7.63%

1Y return CAGR

9.31%

1Y total return

9.3%

20-day SMA

ARS 66,522.50

200-day SMA

ARS 69,061.50

3M price change

3M total return

4.65%

3Y price change

152.81%

3Y return CAGR

38.35%

3Y total return

164.86%

50-day SMA

ARS 65,909.50

50-day SMA vs 200-day SMA

50under200

52-week high

ARS 80,275.00

52-week high date

2026-07-03

52-week low

ARS 54,750.00

52-week low date

2025-10-27

5Y price change

1,020.64%

5Y return CAGR

64.07%

5Y total return

1,088.6%

6M price change

-0.92%

6M total return

-0.29%

All-time high

ARS 80,275.00

All-time high date

2026-07-03

All-time low

ARS 3,038.00

All-time low date

2020-09-04

Average true range (ATR)

ARS 1,476.20

Average volume

750.8

Change from 52-week high

-12.52%

Change from 52-week low

28.27%

Change from all-time high

-12.52%

Change from all-time low

2,211.55%

Change from open

-1.4%

Day's gap

-1.01%

Dollar volume

ARS 90.9M

High price

ARS 71,325.00

Low price

ARS 70,100.00

Monthly RSI

62.83

Open price

ARS 71,225.00

Position in 52-week range

10.2%

Previous close

ARS 71,950.00

Price vs 150-day SMA

3.17%

Price vs 20-day SMA

5.57%

Price vs 200-day SMA

1.68%

Price vs 50-day SMA

6.55%

Relative volume

1.72

RSI

61.64

Sharpe ratio

0.29

Sharpe ratio (3Y)

0.99

Sharpe ratio (5Y)

1.45

Sortino ratio

0.56

Sortino ratio (3Y)

1.68

Sortino ratio (5Y)

2.42

Volume

1.3K

Weekly RSI

54.85

YTD price change

-0.46%

YTD total return

1.09%

Metric	Value
Float	1.5B
Shares change (QoQ)	-0.06%
Shares change (YoY)	-0.03%
Shares held by insiders	0.04%
Shares held by institutions	74.28%

Metric

Value

Float

1.5B

Shares change (QoQ)

-0.06%

Shares change (YoY)

-0.03%

Shares held by insiders

0.04%

Shares held by institutions

74.28%

BCBA/AZN (BCBA/AZN)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/AZN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/AZN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/AZN

Frequently asked questions